8-K/AThe WireRoutine
Company Update
Filed Nov 21, 2025 · 7mo ago · Accession 0001437749-25-036005
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- CIK
- 1719406
- Form type
- 8-K/A
- Filing date
- Nov 21, 2025
- Report date
- Sep 8, 2025
- Document
- nrxp20251118_8ka.htm
- Size
- 1.0 MB